Bluesky Facebook Reddit Email

Biosafety materials: Ushering in a new era of infectious disease diagnosis and treatment with the CRISPR/Cas system

05.05.22 | Compuscript Ltd

Aranet4 Home CO2 Monitor

Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.

https://doi.org/10.1016/j.bsheal.2022.03.010

This article forms part of a special issue - Advanced Biosafety Materials for Prevention and Theranostics of Biosafety Issues – covering the rapid detection and elimination of pathogenic microorganisms and the control of infectious diseases. For the full issue content see: https://www.sciencedirect.com/journal/biosafety-and-health/vol/4/issue/2

Despite multiple virus outbreaks over the past decade, including the devastating coronavirus disease 2019 (COVID-19) pandemic, the lack of accurate and timely diagnosis and treatment technologies has wreaked havoc on global biosecurity. The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated proteins (Cas) system has the potential to address these critical needs for tackling infectious diseases to detect viral nucleic acids and inhibit viral replication.

In this review the authors summarize how the CRISPR/Cas system is being utilized for the treatment and diagnosis of infectious diseases with the help of biosafety materials and highlights the design principle and in vivo and in vitro efficacy of advanced biosafety materials used to deal with virus attacks.

Keywords: Biosafety materials, CRISPR/Cas, SARS-CoV-2, Diagnosis, Infectious disease

# # # # # #

Biosafety and Health is sponsored by the Chinese Medical Association, managed by National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC).

For more information, please visit https://www.journals.elsevier.com/biosafety-and-health

Editorial Board: https://www.sciencedirect.com/journal/biosafety-and-health/about/editorial-board

Biosafety and Health is available on ScienceDirect ( https://www.sciencedirect.com/journal/biosafety-and-health).

Submissions to Biosafety and Health may be made using Editorial Manager ® ( https://www.editorialmanager.com/bsheal/default.aspx ).

CiteScore: 4.8

ISSN 2590-0536

Article reference: Yuquan Zhang, Ziyue Li, Julien Milon Essola, Kun Ge, Xuyan Dai, Huining He, Haihua Xiao, Yuhua Weng, Yuanyu Huang, Biosafety materials: Ushering in a new era of infectious disease diagnosis and treatment with the CRISPR/Cas system, Biosafety and Health , Volume 4, Issue 2, 2022, Pages 70-78, ISSN 2590-0536, https://doi.org/10.1016/j.bsheal.2022.03.010 .

Biosafety and Health

10.1016/j.bsheal.2022.03.010

Keywords

Article Information

Contact Information

Conor Lovett
Compuscript Ltd
c.lovett@cvia-journal.org

How to Cite This Article

APA:
Compuscript Ltd. (2022, May 5). Biosafety materials: Ushering in a new era of infectious disease diagnosis and treatment with the CRISPR/Cas system. Brightsurf News. https://www.brightsurf.com/news/LRD2E3R8/biosafety-materials-ushering-in-a-new-era-of-infectious-disease-diagnosis-and-treatment-with-the-crisprcas-system.html
MLA:
"Biosafety materials: Ushering in a new era of infectious disease diagnosis and treatment with the CRISPR/Cas system." Brightsurf News, May. 5 2022, https://www.brightsurf.com/news/LRD2E3R8/biosafety-materials-ushering-in-a-new-era-of-infectious-disease-diagnosis-and-treatment-with-the-crisprcas-system.html.